SBD/Closing Bell

MLB, MLBPA Announce Significant Changes To Drug Testing Policy

MLB and the MLBPA today announced a series of significant changes to their joint drug agreement, implementing random, in-season blood testing for HGH beginning this year as well as new protocols to test for heightened testosterone. Every player will now have a baseline testostorone/epitestosterone (T/E) ratio determined each year, allowing for easier and more precise detection of subsequent variances beyond allowable limits. The changes, strongly hinted last fall by MLBPA Exec Dir Michael Weiner, furthers what is already the only HGH testing in major North American pro sports and what baseball calls the strongest drug program in all of sports. 

"I can't emphasize enough when I think all that has gone on relative to steroids, when you think of where we were, this is a proud day, a great day for baseball," said MLB Commissioner Bud Selig, speaking following owners' meetings in Paradise Valley, Ariz. "We'll continue to be a leader in this field and do what we have to do."

Read the full story.
Return to top
Video Powered By - Castfire CMS Powered By - Sitecore

Report a Bug